Puluo Pharmaceutical (000739.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 614 million, down 12.37% year on year.

Zhitong Finance APP News, Apeloa Pharmaceutical (000739.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 6.835 billion yuan, a year-on-year decrease of 11.97%; net profit attributable to shareholders of the listed company was 614 million yuan, a year-on-year decrease of 12.37%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 568 million yuan, a year-on-year decrease of 12.22%; basic earnings per share were 0.5309 yuan.